Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6094067 | 1.00 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6095099 | 1.00 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6094072 | 1.00 | SLC6A2 (0.36) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6095793 | 0.93 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6095433 | 0.93 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6095799 | 0.93 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6096193 | 0.90 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6097825 | 0.90 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6097823 | 0.90 | SLC6A4 (0.37) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B | |
| SCHEMBL6097020 | 0.90 | SLC6A2 (0.35) | SLC6A2SLC6A4SLC6A3HTR2CHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004080460-A1 | SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-09-23 | — | — | WO | disclosed |